The ROE as of September 2024 (TTM) for Altimmune, Inc. (ALT) is -60.51%

According to Altimmune, Inc.’s latest financial reports and current stock price. The company's current ROE is -60.51%. This represents a change of 301.34% compared to the average of -15.08% of the last 4 quarters.

Altimmune, Inc. (ALT) Historical ROE (quarterly & annually)

How has ALT ROE performed in the past?

The mean historical ROE of Altimmune, Inc. over the last ten years is 53.82%. The current -60.51% ROE has changed -212.42% with respect to the historical average. Over the past ten years (40 quarters), ALT's ROE was at its highest in in the December 2016 quarter at 399.82%. The ROE was at its lowest in in the September 2017 quarter at -61.24%.

Altimmune, Inc. (ALT) ROE by Quarter and Year

Discovering the peaks and valleys of Altimmune, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Altimmune, Inc. (ALT) Average ROE

How has ALT ROE performed in the past?

The current ROE of Altimmune, Inc. (ALT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Altimmune, Inc. (ALT) ROE vs. Peers

How is ALT’s ROE compared to its peers?

Altimmune, Inc.’s ROE is less than Reviva Pharmaceuticals Holdings, Inc. (7.96%), greater than Athira Pharma, Inc. (-95.53%), greater than Fortress Biotech, Inc. (-226.63%), less than ACADIA Pharmaceuticals Inc. (6.89%), greater than Cabaletta Bio, Inc. (-43.98%), greater than Akero Therapeutics, Inc. (-29.56%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Madrigal Pharmaceuticals, Inc. (-95.61%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Viking Therapeutics, Inc. (-15.05%), greater than Anavex Life Sciences Corp. (-30.62%), greater than Cassava Sciences, Inc. (-10.98%), greater than INmune Bio, Inc. (-101.34%), greater than BioVie Inc. (-294.42%), greater than Cognition Therapeutics, Inc. (-118.11%), greater than Ardelyx, Inc. (-39.73%), greater than Zura Bio Limited (-35.45%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), less than AVROBIO, Inc. (29.68%), greater than Verastem, Inc. (-133.02%), less than X4 Pharmaceuticals, Inc. (32.93%), less than Galera Therapeutics, Inc. (21.95%), greater than Day One Biopharmaceuticals, Inc. (-122.70%), greater than HOOKIPA Pharma Inc. (-51.77%),

Build a custom stock screener for Altimmune, Inc. (ALT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altimmune, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Altimmune, Inc. (ALT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Altimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.